Vaccination against cervical cancer
In June 2006, the organization FDA has authorized the use of vaccination against cervical cancer, which prevents contamination of the virus HPV (human papilloma virus). It is this virus is the cause of most cases of cervical cancer in women.
Cervical cancer is one of the most common diseases in the course of the year zhenschin.V more die from it about 300 thousand women.
HPV is sexually transmitted, and even the use of a condom does not always protect against the possibility of becoming infected. In the case of warts on the skin enough contact with a partner for the site of the skin.
Drug Gardasil (Gardasil) protects against two types of HPV responsible for 70% of cases of cervical cancer. Vaccination also protects against two other types are responsible for 90% of cases of genital warts.
Pharmaceutical company, manufacturer of Gardasil for two years monitored the health of 10.559 women who agreed to participate in a trial of the drug. All the women were aged between 16 and 26 years old, sexually active life and is not a carrier of two varieties of HPV that lead to the formation of cervical cancer. Half of the group received 3 doses over 6 months (and relies on the protocol), the second half of the group received a placebo vaccine.
After two years in the first group did not find a single case of papilloma virus. In the second group receiving a placebo, found 21 ailing woman. 100% success rate in clinical trials is a rare success, and a great reason to celebrate.
Since the vaccine is not fully protects against all cases of cervical cancer, it does not negate the regular check-ups by a specialist – a gynecologist and check PAP Smear.
Israel Ministry of Health recommended to vaccinate girls aged from 11 to 26 years.
One of the first medical institutions in Israel that started vaccination, at the request of the patient, was the clinic “Elisha” in the city of Haifa.